Service
Clinical trial information
A structured search of public trial registries for studies whose published eligibility criteria appear consistent with your documented case.
Who this is for
- Advanced or refractory disease after standard therapy
- Rare conditions with few licensed treatment options
- Patients who have been told no further standard options remain
What is included
- Search of registries including ClinicalTrials.gov, the ISRCTN registry and the EU Clinical Trials Information System
- Shortlist of studies with phase, intervention, recruiting sites and primary endpoint
- Plain-language explanation of inclusion and exclusion criteria that appear relevant to you
- Notes on tests you may need before a site can assess eligibility, such as molecular profiling or performance status
How the review runs
- Step 01
Case parameters
We extract diagnosis, stage, prior lines of therapy, biomarker status and comorbidities from your records.
- Step 02
Registry search
Registries are searched against those parameters and results are filtered for recruiting status and geography.
- Step 03
Shortlist report
You and your treating team receive the shortlist with contact details for each trial site.
Not included
- Enrolment, screening or randomisation — only the trial site can determine eligibility
- Any guarantee that a place is available
- Payment of trial-related travel or treatment costs
MedReview 365 provides independent, informational second opinions based on the records you supply. We do not diagnose, prescribe, or replace the care of your treating clinician. Discuss any recommendation with your own medical team, and call your local emergency number for urgent or deteriorating symptoms.